Dr. Eward is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2301 Erwin Rd
Durham, NC 27705Phone+1 919-684-8111Fax+1 919-681-8921
Summary
- Dr. Eward is an Orthopaedic Oncologist at Duke University. He specializes in treating a rare type of cancer called Sarcoma. He is also a veterinarian and his continued involvement in helping animals with cancer is part of Duke University's strategy to use a multi-species approach to solving the challenges of cancer. His laboratory investigates similarities between dogs and humans with osteosarcoma.
Education & Training
- Duke University HospitalResidency, Orthopaedic Surgery, 2006 - 2011
- University of Vermont College of MedicineClass of 2006
Certifications & Licensure
- NC State Medical License 2006 - 2025
- American Board of Orthopaedic Surgery Orthopaedic Surgery
Clinical Trials
- Evaluating Quality of Life in Patients With Soft Tissue Sarcoma Presenting With Metastatic Lung Disease Start of enrollment: 2014 Mar 01
- Monocyte Phenotypic and Functional Differences Start of enrollment: 2014 Oct 01
- X-ray Psoralen Activated Cancer Therapy in Head and Neck, Breast, Sarcoma and Melanoma Start of enrollment: 2021 Dec 08
Publications & Presentations
PubMed
- Locking plate augmentation of polymethylmethacrylate-filled distal femoral defects: A biomechanical study.Harrison R Ferlauto, Bruno Belanger, Alexander L Lazarides, Julia D Visgauss, Brian E Brigman
Journal of Orthopaedic Research. 2025-01-01 - IlluminOss photodynamic bone stabilization system improves pain and function in the treatment of humeral metastatic disease.Richard M Terek, , Richard McGough, Nicola Fabbri, Felix Cheung
The Bone & Joint Journal. 2024-12-01 - Cell-cycle phase progression analysis identifies three unique phenotypes in soft tissue sarcoma.Mark M Cullen, Alexander L Lazarides, Patricia D Pittman, Etienne M Flamant, Kathryn L Stoeber
BMC Cancer. 2024-10-17
Press Mentions
- Dr. Eward on the Unmet Need for Novel Agents for TGCT and SarcomaFebruary 13th, 2020
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: